Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
about
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesSmall G proteins in the cardiovascular system: physiological and pathological aspectsInhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathwayRho-associated kinase activity is a predictor of cardiovascular outcomes.Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions.Statins and myocardial remodelling: cell and molecular pathways.Rho-kinase inhibition is involved in the activation of PI3-kinase/Akt during ischemic-preconditioning-induced cardiomyocyte apoptosis.Differential roles of endothelin-1 in angiotensin II-induced atherosclerosis and aortic aneurysms in apolipoprotein E-null mice.Wound contraction is attenuated by fasudil inhibition of Rho-associated kinaseThe Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.Cardiac fibroblasts: friend or foe?FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.Increased Rho kinase activity in congestive heart failure.Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient miceAir pollution and cardiac remodeling: a role for RhoA/Rho-kinase.Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration.Simvastatin activates the PPARγ-dependent pathway to prevent left ventricular hypertrophy associated with inhibition of RhoA signaling.Blunted activation of Rho-kinase in yak pulmonary circulation.Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction.Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats.Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.
P2860
Q26825697-76CB0C98-6359-4A9A-9F3C-52BE2F89FAFFQ27010607-FF32994A-EC29-460F-B5DC-C77C6CBAD9E3Q28577117-18B66FA6-C4C0-48E1-8825-826495C11873Q33911873-3182C775-6DF5-49F2-9388-E12B59F5B779Q33968841-8FE0F275-C53C-43F6-A5A4-89301FEA8CC7Q34196628-9B81974D-23C3-4F39-AA7D-54CE45D042E7Q34769863-C71C5C7C-43E5-45F9-811D-111F45EE3BFEQ35168157-6A58305C-442F-43C7-A65F-B63968B6D9F4Q35491880-1D18D9DA-EC60-4948-B701-57B723097C25Q36128353-A80D2FCF-B8D1-46AA-88F3-3E23F395CF23Q36450335-06CDAA4B-02FE-4D6C-8BA9-184D4772F435Q36710880-81F4B5F5-512B-493B-8106-D39DAFE19853Q37000012-300077FC-5A1E-477D-9341-723ACC8FFCB0Q37092280-8D82DB59-F75C-41A1-8662-9581C7C344D7Q37200225-F3131646-E4A6-4B64-901E-1A8BFEC34671Q37728377-887B2553-F762-4A42-8C43-ECD44423DEDFQ37953906-175DDEBD-2363-45F0-8881-A928FF8CA21AQ40581719-6C8399BE-F522-465B-AAC6-43F8A7241B75Q41810359-C477F3D9-22B0-4CFE-8559-C2A6C6976671Q42043334-BA3F36B0-D2D6-4C04-94F9-51ADC44DA759Q46775203-540D998D-9CCC-4463-AE63-B39CFD489E74Q48251701-2A5D3B84-BDA8-43FC-BAD8-302328F46DCDQ49077990-FD77536E-9CB8-4D5E-AF8D-EBBCB28F1486Q50691502-026D88F0-6397-4848-ABB1-04144D273F36Q54543875-EF26D98B-FDA6-49EC-97BF-1FAC725834A9
P2860
Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@en
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@nl
type
label
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@en
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@nl
prefLabel
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@en
Inhibition of Rho-kinase by fa ...... olipoprotein E deficient mice.
@nl
P2093
P1476
Inhibition of Rho-kinase by fa ...... polipoprotein E deficient mice
@en
P2093
Anthony Johns
Baby Martin-McNulty
David R Light
Jon Vincelette
Meredith Halks-Miller
Miriam Schroeder
Mithra Mahmoudi
Valdeci da Cunha
William P Dole
P304
P356
10.1016/J.EJPHAR.2005.02.024
P407
P50
P577
2005-04-01T00:00:00Z